不妊治療市場：製品タイプ、手技、患者タイプ、エンドユーザー別-2025～2030年の世界予測

不妊治療市場は、2023年に53億5,000万米ドルと評価され、2024年には59億3,000万米ドルに達すると予測され、CAGR 11.26％で成長し、2030年には113億米ドルに達すると予測されています。

不妊治療市場には、自然妊娠が不可能な個人やカップルを支援することを目的としたさまざまな治療アプローチが含まれます。これらの治療には、体外受精（IVF）のような生殖補助医療（ART）、不妊治療薬、手術、その他の介入が含まれます。不妊治療の必要性は、ライフスタイル要因、健康状態、出産の遅れなどにより不妊の課題に直面する個人の増加に起因します。最終用途の範囲には、主に不妊治療クリニック、病院、手術センターが含まれ、不妊治療専門センターを通じて提供されるサービスも増加しています。この市場の主な成長要因としては、ARTの技術的進歩、不妊治療に対する資金援助や保険適用の増加、不妊治療に対する意識の高まりなどが挙げられます。しかし、治療に伴う高額な費用、文化的・社会的偏見、地域によって異なる規制状況など、一定の限界や課題も残されています。

最新の潜在的な治療機会は、より費用対効果が高く低侵襲な治療オプションの開発にあり、主に診断ツールの革新と個別化医療アプローチによってもたらされます。さらに、可処分所得の増加や人口動態の変化を考えると、新興市場には大きなビジネスチャンスがあります。利害関係者への調査推奨事項としては、治療の成功率向上と副作用軽減のための研究への投資、ヘルスケアプロバイダーとの提携によるアクセシビリティの向上、不妊問題を非人間的なものとするための顧客教育への取り組みなどが挙げられます。厳しい規制要件やARTに関する倫理的懸念といった限界は、市場の成長を鈍化させる可能性があります。こうした課題にもかかわらず、この市場には革新的な分野があり、特に遺伝子スクリーニングと胚選別技術において、成功率を高め、治療の個別化を洗練させることができます。市場は、医療治療とカウンセリングや栄養指導のような支援サービスを組み合わせた統合ケア・アプローチへと進化しており、消費者の嗜好に合ったホリスティックなソリューションを提供しています。

市場力学：急速に進化する不妊治療市場の主要市場インサイトを公開

不妊治療市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界中で増加するインフラプロジェクト
  • 信頼性と耐久性による電線管への潜在需要
  • スマートグリッドネットワークの急速な拡大
• 市場抑制要因
  • 原材料の電圧に関する懸念
• 市場機会
  • デジタル化による電力使用の急増
  • グリッドインフラの継続的な改修・改修活動
• 市場の課題
  • 配線の欠陥が見つけにくいことと相まって、設置プロセスが困難であること

ポーターの5つの力：不妊治療市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：不妊治療市場における外部からの影響の把握

外部マクロ環境要因は、不妊治療市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析不妊治療市場における競合情勢の把握

不妊治療市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的な意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス不妊治療市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、不妊治療市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨不妊治療市場における成功への道筋を描く

不妊治療市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中でインフラプロジェクトが増加
    • 信頼性と耐久性による電気コンジットの潜在的需要
    • スマートグリッドネットワークの急速な拡大
  • 抑制要因
    • 原材料価格の変動に関する懸念
  • 機会
    • デジタル化による電力使用量の増加
    • グリッドインフラの継続的な改修と改造活動
  • 課題
    • 設置プロセスの難しさと配線の欠陥を見つけるのが難しいこと
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 不妊治療市場：製品別

• アクセサリー
• 装置
  • クライオシステム
  • ガス分析装置
  • イメージングシステム
  • インキュベーター
  • レーザーシステム
  • マイクロマニピュレーターシステム
  • 顕微鏡
  • 卵子吸引ポンプ
  • 精子分析システム
  • 精子分離装置
• メディアと消耗品

第7章 不妊治療市場手順別

• 人工授精
  • 子宮頸管内授精
  • 卵管内授精
  • 子宮内人工授精
• 生殖補助医療
  • 体外受精
    • 配偶子の提供
    • 形態学的に選択された精子の細胞質内注入
  • 卵細胞質内精子注入
  • 代理出産
• 不妊治療手術
  • 子宮鏡検査
  • 腹腔鏡検査
  • 開腹手術
  • 顕微手術による再建
    • 精管精巣吻合術
    • 血管造設術
  • 子宮筋腫摘出術
  • 卵管結紮解除
  • 静脈瘤切除術

第8章 不妊治療市場患者タイプ別

• 女性不妊治療
• 男性不妊治療

第9章 不妊治療市場：エンドユーザー別

• クライオバンク
• 不妊治療センター
• 病院と外科クリニック
• 調査機関

第10章 南北アメリカの不妊治療市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の不妊治療市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの不妊治療市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• ABB Limited
• Aliaxis Group S.A.
• ANAMET Electrical, Inc.
• Astral PolyTechnik Limited
• Atkore International Holdings Incorporated
• Cantex, Inc.
• China Lesso Group Holdings Ltd.
• Dura-line Corporation
• Electri-Flex Company
• Hellermanntyton group plc
• Hubbell Incorporated
• Legrand S.A.
• Nan Ya Plastics Corp.
• National pipe & plastics, Inc.
• Orbia Advance Corporation
• Schneider Electric SE
• Sekisui Chemical Co., Ltd.
• Thomas & Betts Corporation
• Wienerberger AG
• Zekelman Industries Inc.

LIST OF FIGURES

• FIGURE 1. INFERTILITY TREATMENT MARKET RESEARCH PROCESS
• FIGURE 2. INFERTILITY TREATMENT MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL INFERTILITY TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. INFERTILITY TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. INFERTILITY TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. INFERTILITY TREATMENT MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL INFERTILITY TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. INFERTILITY TREATMENT MARKET DYNAMICS
• TABLE 7. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY CRYOSYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY GAS ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY INCUBATORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY LASER SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY MICROMANIPULATOR SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY MICROSCOPES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY OVUM ASPIRATION PUMPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY SPERM ANALYZER SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY SPERM SEPARATION DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY INTRACERVICAL INSEMINATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY INTRATUBAL INSEMINATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY INTRAUTERINE INSEMINATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY GAMETE DONATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY INTRACYTOPLASMIC MORPHOLOGICALLY SELECTED SPERM INJECTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY INTRACYTOPLASMIC SPERM INJECTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY SURROGACY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 37. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY HYSTEROSCOPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 38. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY LAPAROSCOPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 39. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY LAPAROTOMY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 40. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 41. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY VASOEPIDIDYMOSTOMY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 42. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY VASOVASOSTOMY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 43. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
• TABLE 44. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY MYOMECTOMY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 45. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY TUBAL LIGATION REVERSAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 46. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY VARICOCELECTOMY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 47. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
• TABLE 48. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 49. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY TREATMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 50. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY TREATMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 51. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 52. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY CRYOBANKS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 53. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 54. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY HOSPITALS & SURGICAL CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 55. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 56. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 57. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 58. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 59. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
• TABLE 60. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 61. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
• TABLE 62. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
• TABLE 63. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
• TABLE 64. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 65. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 66. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 67. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 68. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 69. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 70. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
• TABLE 71. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 72. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
• TABLE 73. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
• TABLE 74. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
• TABLE 75. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 76. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 77. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 78. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 79. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 80. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
• TABLE 81. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 82. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
• TABLE 83. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
• TABLE 84. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
• TABLE 85. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 86. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 87. CANADA INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 88. CANADA INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 89. CANADA INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 90. CANADA INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
• TABLE 91. CANADA INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 92. CANADA INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
• TABLE 93. CANADA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
• TABLE 94. CANADA INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
• TABLE 95. CANADA INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 96. CANADA INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 97. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 98. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 99. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 100. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
• TABLE 101. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 102. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
• TABLE 103. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
• TABLE 104. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
• TABLE 105. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 106. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 107. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 108. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 109. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 110. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
• TABLE 111. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 112. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
• TABLE 113. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
• TABLE 114. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
• TABLE 115. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 116. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 117. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 118. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 119. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 120. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 121. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
• TABLE 122. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 123. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
• TABLE 124. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
• TABLE 125. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
• TABLE 126. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 127. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 128. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 129. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 130. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 131. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 132. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
• TABLE 133. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 134. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
• TABLE 135. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
• TABLE 136. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
• TABLE 137. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 138. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 139. CHINA INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 140. CHINA INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 141. CHINA INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 142. CHINA INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
• TABLE 143. CHINA INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 144. CHINA INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
• TABLE 145. CHINA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
• TABLE 146. CHINA INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
• TABLE 147. CHINA INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 148. CHINA INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 149. INDIA INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 150. INDIA INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 151. INDIA INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 152. INDIA INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
• TABLE 153. INDIA INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 154. INDIA INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
• TABLE 155. INDIA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
• TABLE 156. INDIA INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
• TABLE 157. INDIA INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 158. INDIA INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 159. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 160. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 161. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 162. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
• TABLE 163. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 164. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
• TABLE 165. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
• TABLE 166. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
• TABLE 167. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 168. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 169. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 170. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 171. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 172. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
• TABLE 173. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 174. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
• TABLE 175. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
• TABLE 176. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
• TABLE 177. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 178. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 179. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 180. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 181. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 182. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
• TABLE 183. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 184. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
• TABLE 185. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
• TABLE 186. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
• TABLE 187. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 188. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 189. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 190. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 191. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 192. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
• TABLE 193. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 194. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
• TABLE 195. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
• TABLE 196. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
• TABLE 197. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 198. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 199. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 200. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 201. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 202. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
• TABLE 203. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 204. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
• TABLE 205. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
• TABLE 206. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
• TABLE 207. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 208. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 209. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 210. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 211. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 212. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
• TABLE 213. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 214. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
• TABLE 215. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
• TABLE 216. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
• TABLE 217. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 218. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 219. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 220. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 221. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 222. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
• TABLE 223. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 224. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
• TABLE 225. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
• TABLE 226. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
• TABLE 227. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 228. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 229. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 230. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 231. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 232. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
• TABLE 233. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 234. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
• TABLE 235. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
• TABLE 236. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
• TABLE 237. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 238. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 239. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 240. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 241. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 242. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
• TABLE 243. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 244. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
• TABLE 245. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
• TABLE 246. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
• TABLE 247. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 248. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 249. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 250. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 251. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 252. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
• TABLE 253. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 254. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
• TABLE 255. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
• TABLE 256. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
• TABLE 257. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 258. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 259. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 260. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 261. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 262. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 263. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
• TABLE 264. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 265. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
• TABLE 266. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
• TABLE 267. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
• TABLE 268. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 269. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 270. EGYPT INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 271. EGYPT INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 272. EGYPT INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 273. EGYPT INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
• TABLE 274. EGYPT INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 275. EGYPT INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
• TABLE 276. EGYPT INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
• TABLE 277. EGYPT INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
• TABLE 278. EGYPT INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 279. EGYPT INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 280. FINLAND INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 281. FINLAND INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 282. FINLAND INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 283. FINLAND INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
• TABLE 284. FINLAND INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 285. FINLAND INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
• TABLE 286. FINLAND INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
• TABLE 287. FINLAND INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
• TABLE 288. FINLAND INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 289. FINLAND INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 290. FRANCE INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 291. FRANCE INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 292. FRANCE INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 293. FRANCE INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
• TABLE 294. FRANCE INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 295. FRANCE INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
• TABLE 296. FRANCE INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
• TABLE 297. FRANCE INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
• TABLE 298. FRANCE INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 299. FRANCE INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 300. GERMANY INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 301. GERMANY INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 302. GERMANY INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 303. GERMANY INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
• TABLE 304. GERMANY INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 305. GERMANY INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
• TABLE 306. GERMANY INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
• TABLE 307. GERMANY INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
• TABLE 308. GERMANY INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 309. GERMANY INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 310. ISRAEL INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 311. ISRAEL INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 312. ISRAEL INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 313. ISRAEL INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
• TABLE 314. ISRAEL INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 315. ISRAEL INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
• TABLE 316. ISRAEL INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
• TABLE 317. ISRAEL INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
• TABLE 318. ISRAEL INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 319. ISRAEL INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 320. ITALY INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 321. ITALY INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 322. ITALY INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 323. ITALY INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATIO

The Infertility Treatment Market was valued at USD 5.35 billion in 2023, expected to reach USD 5.93 billion in 2024, and is projected to grow at a CAGR of 11.26%, to USD 11.30 billion by 2030.

The infertility treatment market encompasses a range of therapeutic approaches aimed at aiding individuals and couples unable to conceive naturally. These treatments include assisted reproductive technologies (ART) like in vitro fertilization (IVF), fertility drugs, surgeries, and other interventions. The necessity for infertility treatments arises from the growing number of individuals facing fertility challenges due to lifestyle factors, health conditions, and delayed childbearing. The end-use scope primarily includes fertility clinics, hospitals, and surgical centers, with an increasing number of services also being offered through specialized fertility centers. Key growth factors for this market include technological advancements in ART, increased funding and insurance coverage for infertility treatments, and growing awareness regarding fertility preservation. However, certain limitations and challenges remain, such as the high costs associated with treatments, cultural and social stigmas, and varying regulatory landscapes across regions.

Latest potential opportunities lie in the development of more cost-effective and minimally invasive treatment options, largely driven by innovation in diagnostic tools and personalized medicine approaches. Additionally, emerging markets present significant opportunities, given the increasing disposable income and changing demographics. Recommendations for stakeholders include investing in research to improve success rates of treatments and reduce side-effects, enhancing accessibility through partnerships with healthcare providers, and engaging in customer education initiatives to destigmatize infertility issues. Limitations such as stringent regulatory requirements and ethical concerns related to ART can slow down market growth. Despite these challenges, the market offers areas of innovation, particularly in genetic screening and embryo selection technologies, which can increase success rates and refine personalization in treatments. The market is evolving towards an integrated care approach, combining medical treatments with supportive services like counseling and nutritional guidance, offering a holistic solution that is gaining favor in consumer preferences.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Infertility Treatment Market

The Infertility Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising number of infrastructure projects all over the world
  • Potential demand for electrical conduit owing to reliability and durability
  • Rapid extension of smart grid networks
• Market Restraints
  • Concern associated with raw material voltality
• Market Opportunities
  • Proliferation of electricity usage attributed to digitalization
  • Ongoing refurbishment and retrofit activities in grid infrastructure
• Market Challenges
  • Difficulty in installation process coupled with hard to find defects in wiring

Porter's Five Forces: A Strategic Tool for Navigating the Infertility Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Infertility Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Infertility Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Infertility Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Infertility Treatment Market

A detailed market share analysis in the Infertility Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Infertility Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Infertility Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Infertility Treatment Market

A strategic analysis of the Infertility Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Infertility Treatment Market, highlighting leading vendors and their innovative profiles. These include ABB Limited, Aliaxis Group S.A., ANAMET Electrical, Inc., Astral PolyTechnik Limited, Atkore International Holdings Incorporated, Cantex, Inc., China Lesso Group Holdings Ltd., Dura-line Corporation, Electri-Flex Company, Hellermanntyton group plc, Hubbell Incorporated, Legrand S.A., Nan Ya Plastics Corp., National pipe & plastics, Inc., Orbia Advance Corporation, Schneider Electric SE, Sekisui Chemical Co., Ltd., Thomas & Betts Corporation, Wienerberger AG, and Zekelman Industries Inc..

Market Segmentation & Coverage

This research report categorizes the Infertility Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Accessories, Equipment, and Media & Consumables. The Equipment is further studied across Cryosystems, Gas Analyzers, Imaging Systems, Incubators, Laser Systems, Micromanipulator Systems, Microscopes, Ovum Aspiration Pumps, Sperm Analyzer Systems, and Sperm Separation Devices.
• Based on Procedure, market is studied across Artificial Insemination, Assisted Reproductive Technology, and Fertility Surgeries. The Artificial Insemination is further studied across Intracervical Insemination, Intratubal Insemination, and Intrauterine Insemination. The Assisted Reproductive Technology is further studied across In Vitro Fertilization, Intracytoplasmic Sperm Injection, and Surrogacy. The In Vitro Fertilization is further studied across Gamete Donation and Intracytoplasmic Morphologically Selected Sperm Injection. The Fertility Surgeries is further studied across Hysteroscopy, Laparoscopy, Laparotomy, Microsurgical Reconstruction, Myomectomy, Tubal Ligation Reversal, and Varicocelectomy. The Microsurgical Reconstruction is further studied across Vasoepididymostomy and Vasovasostomy.
• Based on Patient type, market is studied across Female Infertility Treatment and Male Infertility Treatment.
• Based on End User, market is studied across Cryobanks, Fertility Centers, Hospitals & Surgical Clinics, and Research Institutes.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising number of infrastructure projects all over the world
    • 5.1.1.2. Potential demand for electrical conduit owing to reliability and durability
    • 5.1.1.3. Rapid extension of smart grid networks
  • 5.1.2. Restraints
    • 5.1.2.1. Concern associated with raw material voltality
  • 5.1.3. Opportunities
    • 5.1.3.1. Proliferation of electricity usage attributed to digitalization
    • 5.1.3.2. Ongoing refurbishment and retrofit activities in grid infrastructure
  • 5.1.4. Challenges
    • 5.1.4.1. Difficulty in installation process coupled with hard to find defects in wiring
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Infertility Treatment Market, by Product

• 6.1. Introduction
• 6.2. Accessories
• 6.3. Equipment
  • 6.3.1. Cryosystems
  • 6.3.2. Gas Analyzers
  • 6.3.3. Imaging Systems
  • 6.3.4. Incubators
  • 6.3.5. Laser Systems
  • 6.3.6. Micromanipulator Systems
  • 6.3.7. Microscopes
  • 6.3.8. Ovum Aspiration Pumps
  • 6.3.9. Sperm Analyzer Systems
  • 6.3.10. Sperm Separation Devices
• 6.4. Media & Consumables

7. Infertility Treatment Market, by Procedure

• 7.1. Introduction
• 7.2. Artificial Insemination
  • 7.2.1. Intracervical Insemination
  • 7.2.2. Intratubal Insemination
  • 7.2.3. Intrauterine Insemination
• 7.3. Assisted Reproductive Technology
  • 7.3.1. In Vitro Fertilization
    • 7.3.1.1. Gamete Donation
    • 7.3.1.2. Intracytoplasmic Morphologically Selected Sperm Injection
  • 7.3.2. Intracytoplasmic Sperm Injection
  • 7.3.3. Surrogacy
• 7.4. Fertility Surgeries
  • 7.4.1. Hysteroscopy
  • 7.4.2. Laparoscopy
  • 7.4.3. Laparotomy
  • 7.4.4. Microsurgical Reconstruction
    • 7.4.4.1. Vasoepididymostomy
    • 7.4.4.2. Vasovasostomy
  • 7.4.5. Myomectomy
  • 7.4.6. Tubal Ligation Reversal
  • 7.4.7. Varicocelectomy

8. Infertility Treatment Market, by Patient type

• 8.1. Introduction
• 8.2. Female Infertility Treatment
• 8.3. Male Infertility Treatment

9. Infertility Treatment Market, by End User

• 9.1. Introduction
• 9.2. Cryobanks
• 9.3. Fertility Centers
• 9.4. Hospitals & Surgical Clinics
• 9.5. Research Institutes

10. Americas Infertility Treatment Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Infertility Treatment Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Infertility Treatment Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. ABB Limited
• 2. Aliaxis Group S.A.
• 3. ANAMET Electrical, Inc.
• 4. Astral PolyTechnik Limited
• 5. Atkore International Holdings Incorporated
• 6. Cantex, Inc.
• 7. China Lesso Group Holdings Ltd.
• 8. Dura-line Corporation
• 9. Electri-Flex Company
• 10. Hellermanntyton group plc
• 11. Hubbell Incorporated
• 12. Legrand S.A.
• 13. Nan Ya Plastics Corp.
• 14. National pipe & plastics, Inc.
• 15. Orbia Advance Corporation
• 16. Schneider Electric SE
• 17. Sekisui Chemical Co., Ltd.
• 18. Thomas & Betts Corporation
• 19. Wienerberger AG
• 20. Zekelman Industries Inc.